Supreme Court Dismisses Mifepristone Case, Future Challenges Loom

The unanimous ruling preserves access to the abortion pill but leaves room for ongoing legal battles.

The Supreme Court dismissed a case challenging the FDA's approval of mifepristone due to lack of standing.
Legal experts warn that the ruling does not address the merits of the case, leaving it vulnerable to future challenges.
State legislatures and lower courts may continue to pose threats to medication abortion access.
The Comstock Act remains a potential tool for restricting the distribution of abortion medications.
Reproductive rights advocates emphasize the need for continued vigilance and legislative action.